These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Retrospective and prospective studies on the clinical effect of clopenthixol (sordinol) in endogenous phychoses]. Hicklin A; Angst J Schweiz Med Wochenschr; 1967 May; 97(19):615-21. PubMed ID: 5600894 [No Abstract] [Full Text] [Related]
27. Mesoridazine in acute psychotic disturbances. Ast H; Amin M; Saxena BM; Lehmann HE; Ban TA Curr Ther Res Clin Exp; 1967 Dec; 9(12):623-5. PubMed ID: 4965458 [No Abstract] [Full Text] [Related]
28. Liquid butaperazine in the treatment of chronic psychosis in a mental health clinic. Clare G; Simeon J; Fink M Curr Ther Res Clin Exp; 1969 Feb; 11(2):57-63. PubMed ID: 4388407 [No Abstract] [Full Text] [Related]
29. [Indications for the use of neuleptil. Review of the literature and clinical contribution]. Catalano A; Del Pistoia L; De Risio C; Ridolo P Riv Sper Freniatr Med Leg Alien Ment; 1967; 91():Suppl 5:1307+. PubMed ID: 4388059 [No Abstract] [Full Text] [Related]
30. Three long-acting neuroleptic drugs. Comparative study. de Francisco CP Int J Neurol; 1975; 10(1-4):41-5. PubMed ID: 1181318 [No Abstract] [Full Text] [Related]
31. [Preliminary study corncerning the treatment of chronic psychoses with Flupenthixol decanoate]. Brasseur R Schweiz Rundsch Med Prax; 1971 Aug; 60(33):1107-13. PubMed ID: 5562153 [No Abstract] [Full Text] [Related]
32. [Sulpiride and psychoses. Apropos of 112 cases]. Sutter JM; Couderc L; Scotto JC; Dufour H; Luccioni H; Martin M; Saut G; Poisson D; Crespin J; Huber JP Ann Med Psychol (Paris); 1971 Jan; 1(1):102-12. PubMed ID: 5553966 [No Abstract] [Full Text] [Related]
33. [Comparative study of the activity of 2 neuroleptics]. Blanc M; Borenstein P; Brion S; Buisson JF; Debray HR; Digo R; Flavigny H; Follin S; Minvielle J; Morel-Maroger A; Pichot P; Rainaut J; Sutter JM Encephale; 1970; 59(2):97-161. PubMed ID: 5458713 [No Abstract] [Full Text] [Related]
34. Evaluation of piperacetazine (Quide) injection in acute schizophrenics. Kiev A; Güclü B; Kulkarni AS Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517 [No Abstract] [Full Text] [Related]
35. [Experiences with depot form flupenthixol]. Bruck J; Guss H Wien Med Wochenschr; 1971 Feb; 121(7):110-2. PubMed ID: 5545657 [No Abstract] [Full Text] [Related]
36. Quide vs. Mellaril in chronic schizophrenic patients. Gallant DM; Bishop MP Curr Ther Res Clin Exp; 1972 Jan; 14(1):10-6. PubMed ID: 4621558 [No Abstract] [Full Text] [Related]
37. Long-acting tranquillizers. Johnson DA; Freeman H Practitioner; 1972 Mar; 208(245):395-400. PubMed ID: 5025560 [No Abstract] [Full Text] [Related]
38. Effects of drug withdrawal on tardive dyskinesia. Crane GE; Ruiz P; Kernohan WJ; Wilson W; Royalty N Act Nerv Super (Praha); 1969; 11(1):30-5. PubMed ID: 5770140 [No Abstract] [Full Text] [Related]
39. Antipsychotic properties of loxapine succinate. Gershon S; Hekimian LJ; Burdock EI; Kim SS Curr Ther Res Clin Exp; 1970 May; 12(5):280-5. PubMed ID: 4986243 [No Abstract] [Full Text] [Related]
40. [On the use of sulpiride in psychiatric therapy]. Naviau J Ann Med Psychol (Paris); 1969 Jun; 2(1):108-16. PubMed ID: 5376631 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]